Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $120,225 - $146,454
2,100 Added 262.5%
2,900 $174,000
Q3 2023

Nov 14, 2023

BUY
$63.16 - $76.5 $50,528 - $61,200
800 New
800 $53,000
Q1 2023

May 15, 2023

SELL
$43.42 - $57.37 $99,866 - $131,951
-2,300 Reduced 36.51%
4,000 $192,000
Q4 2022

Feb 14, 2023

SELL
$38.8 - $55.46 $496,639 - $709,888
-12,800 Reduced 67.02%
6,300 $314,000
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $240,345 - $359,730
6,300 Added 49.22%
19,100 $779,000
Q2 2022

Aug 08, 2022

BUY
$33.54 - $55.0 $429,312 - $704,000
12,800 New
12,800 $704,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.68B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.